HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- ASX ANNOUNCEMENTS
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
- PRESENTATIONS & VIDEOS
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2015
- REPORTS
- STOCK INFORMATION
- CORPORATE GOVERNANCE
MEDIA
CONTACT

HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- - ASX ANNOUNCEMENTS
  - - 2021
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
- - PRESENTATIONS & VIDEOS
  - - 2021
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
  - - 2015
- - REPORTS
- - STOCK INFORMATION
- - CORPORATE GOVERNANCE
MEDIA
CONTACT

REPORTS

REPORTS

Sequoia Initiation Research Report, 19 August 2020 19/08/2020
Viriathus Research Report, 13 September 2018 24/01/2019

SUBSCRIBE

Leave this field empty if you're human:

Zelira TherapeuticsFollow

Zelira Therapeutics Ltd (“Zelira”) is a leading global medicinal cannabis company with access to the world's largest and fastest growing cannabis markets.

“The boldest voices will always be heard, but the best ideas and solutions can also come in whispers.”

Zelira CEO Oludare Odumosu, continues to offer more expert advice as part of Rolling Stone magazine's invitation-only Culture Council.

Read more: http://ow.ly/xR0f50GmAQK

Twitter 1445538278581571591

CONTACT US

Copyright © Zelira Therapeutics. All rights reserved. | Disclaimer.